JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB109264

Anti-USP13 抗体 [EPR4348]

Anti-USP13 antibody [EPR4348]

4

(2 Reviews)

|

(13 Publications)

Rabbit Recombinant Monoclonal USP13 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Mouse samples. Cited in 13 publications.

別名を表示する

ISOT3, USP13, Ubiquitin carboxyl-terminal hydrolase 13, Deubiquitinating enzyme 13, Isopeptidase T-3, Ubiquitin thioesterase 13, Ubiquitin-specific-processing protease 13, ISOT-3

6 Images
Immunocytochemistry/ Immunofluorescence - Anti-USP13 antibody [EPR4348] (AB109264)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-USP13 antibody [EPR4348] (AB109264)

ICC/IF image of ab109264 stained MCF-7 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody ab109264 at 10μg/ml overnight at +4°C. The secondary antibody (green) was DyLight® 488 goat anti- rabbit (ab96899) IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.

Flow Cytometry (Intracellular) - Anti-USP13 antibody [EPR4348] (AB109264)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-USP13 antibody [EPR4348] (AB109264)

Overlay histogram showing SHSY-5Y cells stained with ab109264 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab109264 1/9400 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H&L) (ab150077) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter. This antibody gave a positive signal in SHSY-5Y cells fixed with 80% methanol (5 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.

Immunocytochemistry/ Immunofluorescence - Anti-USP13 antibody [EPR4348] (AB109264)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-USP13 antibody [EPR4348] (AB109264)

Immunocytochemistry/Immunofluorescence analysis of Neuro-2a (Mouse neuroblastoma cell line) labeling USP13 with Purified ab109264 at 1/500 dilution (5 μg/ml). Cells were fixed with 100% methanol. ab150077 Goat anti rabbit IgG(Alexa Fluor® 488) at 1/1000 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI. PBS was used instead of the primary antibody as the negative control.

Western blot - Anti-USP13 antibody [EPR4348] (AB109264)
  • WB

Lab

Western blot - Anti-USP13 antibody [EPR4348] (AB109264)

Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : USP13 knockout HAP1 cell lysate (20 μg)
Lane 3 : A375 cell lysate (20 μg)
Lane 4 : SH-SY5Y cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab109264 observed at 100 kDa. Red - loading control, ab8245, observed at 37 kDa.

ab109264 was shown to recognize USP13 when USP13 knockout samples were used, along with additional cross-reactive bands. Wild-type and USP13 knockout samples were subjected to SDS-PAGE. ab109264 and ab8245 (loading control to GAPDH) were diluted 1/1000 and 1/10 000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-USP13 antibody [EPR4348] (ab109264)

Predicted band size: 97 kDa

false

Western blot - Anti-USP13 antibody [EPR4348] (AB109264)
  • WB

Unknown

Western blot - Anti-USP13 antibody [EPR4348] (AB109264)

All lanes:

Western blot - Anti-USP13 antibody [EPR4348] (ab109264) at 1/1000 dilution

Lane 1:

SH SY5Y cell lysate at 10 µg

Lane 2:

HepG2 cell lysate at 10 µg

Lane 3:

A375 cell lysate at 10 µg

Predicted band size: 97 kDa

Observed band size: 97 kDa

false

Western blot - Anti-USP13 antibody [EPR4348] (AB109264)
  • WB

CiteAb

Western blot - Anti-USP13 antibody [EPR4348] (AB109264)

USP13 western blot using anti-USP13 antibody [EPR4348] ab109264. Publication image and figure legend from Liao, Y., Guo, Z., et al., 2019, J Exp Clin Cancer Res, PubMed 30975171.

ab109264 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab109264 please see the product overview.

Spautin-1 induces G0/G1 phase arrest via down-regulating Cyclin D1 in PCa cells. a Fluorescence-activated cell sorting analysis (FACS) was performed to analyze cell cycle distributions of PCa cells exposed to Spautin-1 or SKP2-C25 for 24 h. A summary of cell cycle distributions was shown from three independent experiments. b Western blot analysis was performed to detect the expression of CDK4, CDK2, Cyclin D1, P15 and P21 in PCa cells exposed to various doses of Spautin-1 (0, 5, 10, 20 μM) for 24 h (left), or Spautin-1 (10 μM) at various lengths of time (Right). c Western blot analysis was performed to detect the expression of CDK4, CDK2, Cyclin D1, USP10 and USP13 in PCa cells exposed to USP10 siRNA or USP13 siRNA for 48 h. d FACS was performed to analyze cell cycle distributions of PCa cells exposed to USP10 siRNA or USP13 siRNA for 48 h. e 22Rv1 and PC3 cells were transfected with HA-Cyclin D1 and/or FLAG-CDK2 for 48 h. Cell viability analysis was performed on the above cells exposed to Spautin-1 for 24 h. #p<0.05. f Western blot of CDK2 and Cyclin D1 to verified the overexpression in PC3 cells. Sp-1 : Spautin-1

false

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR4348

アイソタイプ

IgG

キャリアフリー

No

交差種

Mouse, Human

アプリケーション

ICC/IF, Flow Cyt (Intra), WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "10 µg/mL", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/940 - 1/9400", "FlowCytIntra-species-notes": "<p><a href='/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" }, "Mouse": { "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "10 µg/mL", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

製品の詳細

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Species reactivity
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.05% Sodium azide Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine, 0.1% BSA
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
-20°C
保管に関する情報
Stable for 12 months at -20°C

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

USP13 also known as Ubiquitin Specific Protease 13 functions as a deubiquitinating enzyme. It is important in removing ubiquitin molecules from protein substrates which prevents them from being degraded by the proteasome system. USP13 has a molecular mass of approximately 97 kDa and shows expression in several tissues including brain heart and kidney. This indicates its diverse role in human physiology.
Biological function summary

USP13 participates in maintaining protein homeostasis and modulates protein stability. It forms complexes with specific substrate proteins to execute its function efficiently. Through deubiquitinating actions it regulates the levels of proteins involved in cellular signaling apoptosis and cell cycle control. The enzyme influences processes that are important for cell survival and adaptation to stress.

Pathways

USP13 plays significant roles within the ubiquitin-proteasome system and the mitophagy pathway. It cooperates with proteins like Parkin in mitochondrial quality control by stabilizing target proteins necessary for mitophagy. Through interaction with key players in these pathways USP13 ensures the maintenance of cellular health and proper degradation of damaged or misfolded proteins.

USP13 has associations with cancer and neurodegenerative diseases. Overexpression of USP13 might contribute to tumor progression by inhibiting degradation of oncoproteins. It also shows connections to disorders like Parkinson's disease where it interacts with proteins such as Parkin and PINK1 which are important for mitochondrial function. These interactions highlight USP13's potential as a target for therapeutic interventions.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Deubiquitinase that mediates deubiquitination of target proteins such as BECN1, MITF, SKP2 and USP10 and is involved in various processes such as autophagy, endoplasmic reticulum-associated degradation (ERAD), cell cycle progression or DNA damage response (PubMed : 21571647, PubMed : 32772043, PubMed : 33592542). Component of a regulatory loop that controls autophagy and p53/TP53 levels : mediates deubiquitination of BECN1, a key regulator of autophagy, leading to stabilize the PIK3C3/VPS34-containing complexes. Alternatively, forms with NEDD4 a deubiquitination complex, which subsequently stabilizes VPS34 to promote autophagy (PubMed : 32101753). Also deubiquitinates USP10, an essential regulator of p53/TP53 stability. In turn, PIK3C3/VPS34-containing complexes regulate USP13 stability, suggesting the existence of a regulatory system by which PIK3C3/VPS34-containing complexes regulate p53/TP53 protein levels via USP10 and USP13. Recruited by nuclear UFD1 and mediates deubiquitination of SKP2, thereby regulating endoplasmic reticulum-associated degradation (ERAD). Also regulates ERAD through the deubiquitination of UBL4A a component of the BAG6/BAT3 complex. Mediates stabilization of SIAH2 independently of deubiquitinase activity : binds ubiquitinated SIAH2 and acts by impairing SIAH2 autoubiquitination. Regulates the cell cycle progression by stabilizing cell cycle proteins such as SKP2 and AURKB (PubMed : 32772043). In addition, plays an important role in maintaining genomic stability and in DNA replication checkpoint activation via regulation of RAP80 and TOPBP1 (PubMed : 33592542). Deubiquitinates the multifunctional protein HMGB1 and subsequently drives its nucleocytoplasmic localization and its secretion (PubMed : 36585612). Positively regulates type I and type II interferon signalings by deubiquitinating STAT1 but negatively regulates antiviral response by deubiquitinating STING1 (PubMed : 23940278, PubMed : 28534493).
See full target information USP13

文献 (13)

Recent publications for all applications. Explore the full list and refine your search

Oncology research 33:1947-1967 PubMed40746889

2025

USP13 Suppresses Colorectal Cancer Angiogenesis by Downregulating VEGFA Expression through Inhibition of the PTEN-AKT Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Guo-Zhi Xu,Han-Yang Guan,Yan-Guan Guo,Yi-Ran Zhang,Jing-Hua Pan,Simin Luo,Hui Ding,Yunlong Pan,Qi Yao

Acta pharmaceutica Sinica. B 13:1071-1092 PubMed36970206

2023

The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis blocking inactive rhomboid protein 2-dependent pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Minxuan Xu,Jun Tan,Liancai Zhu,Chenxu Ge,Wei Dong,Xianling Dai,Qin Kuang,Shaoyu Zhong,Lili Lai,Chao Yi,Qiang Li,Deshuai Lou,Linfeng Hu,Xi Liu,Gang Kuang,Jing Luo,Jing Feng,Bochu Wang

Cellular oncology (Dordrecht) 46:717-733 PubMed36732432

2023

USP13 promotes breast cancer metastasis through FBXL14-induced Twist1 ubiquitination.

Applications

Unspecified application

Species

Unspecified reactive species

Binggong Zhao,Wei Huo,Xiaomin Yu,Xiaoxia Shi,Linlin Lv,Yuxi Yang,Jie Kang,Shujing Li,Huijian Wu

Cell death and differentiation 30:544-559 PubMed36528756

2022

N-methyladenosine-modified USP13 induces pro-survival autophagy and imatinib resistance via regulating the stabilization of autophagy-related protein 5 in gastrointestinal stromal tumors.

Applications

Unspecified application

Species

Unspecified reactive species

Zhishuang Gao,Chao Li,Haoyu Sun,Yibo Bian,Zhiwei Cui,Nuofan Wang,Zhangjie Wang,Yang Yang,Zonghang Liu,Zhongyuan He,Bowen Li,Fengyuan Li,Zheng Li,Linjun Wang,Diancai Zhang,Li Yang,Zekuan Xu,Xueming Li,Hao Xu

Nature communications 13:5435 PubMed36114200

2022

Electrostatic and steric effects underlie acetylation-induced changes in ubiquitin structure and function.

Applications

Unspecified application

Species

Unspecified reactive species

Simon Maria Kienle,Tobias Schneider,Katrin Stuber,Christoph Globisch,Jasmin Jansen,Florian Stengel,Christine Peter,Andreas Marx,Michael Kovermann,Martin Scheffner

Proceedings of the National Academy of Sciences of the United States of America 119:e2119854119 PubMed36037364

2022

USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Haibiao Xie,Jin Zhou,Xijuan Liu,Yawei Xu,Austin J Hepperla,Jeremy M Simon,Tao Wang,Hongwei Yao,Chengheng Liao,Albert S Baldwin,Kan Gong,Qing Zhang

The EMBO journal 41:e109187 PubMed35191554

2022

USP33 deubiquitinates and stabilizes HIF-2alpha to promote hypoxia response in glioma stem cells.

Applications

Unspecified application

Species

Unspecified reactive species

Aili Zhang,Zhi Huang,Weiwei Tao,Kui Zhai,Qiulian Wu,Jeremy N Rich,Wenchao Zhou,Shideng Bao

Nature communications 12:3497 PubMed34108453

2021

Site-specific ubiquitylation acts as a regulator of linker histone H1.

Applications

Unspecified application

Species

Unspecified reactive species

Eva Höllmüller,Simon Geigges,Marie L Niedermeier,Kai-Michael Kammer,Simon M Kienle,Daniel Rösner,Martin Scheffner,Andreas Marx,Florian Stengel

Acta biochimica Polonica 68:201-206 PubMed33966370

2021

miR-19a-3p inhibition alleviates sepsis-induced lung injury via enhancing USP13 expression.

Applications

Unspecified application

Species

Unspecified reactive species

Hangqi Ren,Wei Mu,Qiaolian Xu

Cancer management and research 11:9175-9183 PubMed31802942

2019

USP13 serves as a tumor suppressor via the PTEN/AKT pathway in oral squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Zhi Qu,Ran Zhang,Meng Su,Weixian Liu
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com